Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015-2017).
Adult
Aged
Female
Hospitalization
Humans
Influenza A Virus, H1N1 Subtype
/ isolation & purification
Influenza A Virus, H3N2 Subtype
/ isolation & purification
Intensive Care Units
Logistic Models
Male
Middle Aged
Odds Ratio
Pneumocystis carinii
/ isolation & purification
Prospective Studies
Respiratory Tract Infections
/ diagnosis
Survival Rate
Vietnam
/ epidemiology
A(H1N1)pdm09
Acute respiratory infection
Multiplex real-time PCR
Respiratory microbes
Vietnam
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
06 Apr 2021
06 Apr 2021
Historique:
received:
19
06
2020
accepted:
15
03
2021
entrez:
7
4
2021
pubmed:
8
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
Acute respiratory tract infection (ARI) is a leading cause of hospitalization, morbidity, and mortality worldwide. Respiratory microbes that were simultaneously detected in the respiratory tracts of hospitalized adult ARI patients were investigated. Associations between influenza A(H1N1)pdm09 virus (H1N1pdm) detection and intensive care unit (ICU) admission or fatal outcome were determined. This prospective observational study was conducted between September 2015 and June 2017 at Bach Mai Hospital, Hanoi, Vietnam. Inclusion criteria were hospitalized patients aged ≥15 years; one or more of symptoms including shortness of breath, sore throat, runny nose, headache, and muscle pain/arthralgia in addition to cough and fever > 37.5 °C; and ≤ 10 days from the onset of symptoms. Twenty-two viruses, 11 bacteria, and one fungus in airway specimens were examined using a commercial multiplex real-time PCR assay. Associations between H1N1pdm detection and ICU admission or fatal outcome were investigated by univariate and multivariate logistic regression analyses. The total of 269 patients (57.6% male; median age, 51 years) included 69 ICU patients. One or more microbes were detected in the airways of 214 patients (79.6%). Single and multiple microbes were detected in 41.3 and 38.3% of patients, respectively. Influenza A(H3N2) virus was the most frequently detected (35 cases; 13.0%), followed by H1N1pdm (29 cases; 10.8%). Hematological disease was associated with ICU admission (p < 0.001) and fatal outcomes (p < 0.001) using the corrected significance level (p = 0.0033). Sex, age, duration from onset to sampling, or number of detected microbes were not significantly associated with ICU admission or fatal outcomes. H1N1pdm detection was associated with ICU admission (odds ratio [OR] 3.911; 95% confidence interval [CI] 1.671-9.154) and fatal outcome (OR 5.496; 95% CI 1.814-16.653) after adjusting for the confounding factors of comorbidities, bacteria/Pneumocystis jirovecii co-detection, and age. H1N1pdm was associated with severe morbidity and death in adult patients hospitalized with respiratory symptoms. The diagnosis of subtype of influenza virus may be epidemiologically important.
Sections du résumé
BACKGROUND
BACKGROUND
Acute respiratory tract infection (ARI) is a leading cause of hospitalization, morbidity, and mortality worldwide. Respiratory microbes that were simultaneously detected in the respiratory tracts of hospitalized adult ARI patients were investigated. Associations between influenza A(H1N1)pdm09 virus (H1N1pdm) detection and intensive care unit (ICU) admission or fatal outcome were determined.
METHODS
METHODS
This prospective observational study was conducted between September 2015 and June 2017 at Bach Mai Hospital, Hanoi, Vietnam. Inclusion criteria were hospitalized patients aged ≥15 years; one or more of symptoms including shortness of breath, sore throat, runny nose, headache, and muscle pain/arthralgia in addition to cough and fever > 37.5 °C; and ≤ 10 days from the onset of symptoms. Twenty-two viruses, 11 bacteria, and one fungus in airway specimens were examined using a commercial multiplex real-time PCR assay. Associations between H1N1pdm detection and ICU admission or fatal outcome were investigated by univariate and multivariate logistic regression analyses.
RESULTS
RESULTS
The total of 269 patients (57.6% male; median age, 51 years) included 69 ICU patients. One or more microbes were detected in the airways of 214 patients (79.6%). Single and multiple microbes were detected in 41.3 and 38.3% of patients, respectively. Influenza A(H3N2) virus was the most frequently detected (35 cases; 13.0%), followed by H1N1pdm (29 cases; 10.8%). Hematological disease was associated with ICU admission (p < 0.001) and fatal outcomes (p < 0.001) using the corrected significance level (p = 0.0033). Sex, age, duration from onset to sampling, or number of detected microbes were not significantly associated with ICU admission or fatal outcomes. H1N1pdm detection was associated with ICU admission (odds ratio [OR] 3.911; 95% confidence interval [CI] 1.671-9.154) and fatal outcome (OR 5.496; 95% CI 1.814-16.653) after adjusting for the confounding factors of comorbidities, bacteria/Pneumocystis jirovecii co-detection, and age.
CONCLUSIONS
CONCLUSIONS
H1N1pdm was associated with severe morbidity and death in adult patients hospitalized with respiratory symptoms. The diagnosis of subtype of influenza virus may be epidemiologically important.
Identifiants
pubmed: 33823790
doi: 10.1186/s12879-021-05988-x
pii: 10.1186/s12879-021-05988-x
pmc: PMC8023524
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
320Subventions
Organisme : the Agency for Medical Research and Development (AMED), Japan
ID : JP18fk0108103, JP20fk0108082
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : JP20K07400
Références
J Infect Dis. 2016 Feb 15;213(4):584-91
pubmed: 26180044
BMC Infect Dis. 2018 Sep 14;18(1):462
pubmed: 30217168
Sci Rep. 2017 Apr 20;7(1):929
pubmed: 28428558
J Med Virol. 2017 Jul;89(7):1186-1191
pubmed: 28004402
Virol J. 2015 Oct 14;12:168
pubmed: 26467854
J Clin Virol. 2019 Aug;117:73-79
pubmed: 31238274
BMC Pulm Med. 2019 Jul 18;19(1):132
pubmed: 31319825
Indian J Pediatr. 2019 May;86(5):433-438
pubmed: 30637585
BMC Public Health. 2019 May 3;19(1):499
pubmed: 31053069
Thorax. 2006 Jan;61(1):75-9
pubmed: 16227331
J Med Virol. 2016 Nov;88(11):1874-81
pubmed: 27061822
PLoS One. 2013 Aug 23;8(8):e72174
pubmed: 24058410
J Med Virol. 2019 Jul;91(7):1202-1209
pubmed: 30801727
Pediatr Infect Dis J. 2010 Jan;29(1):75-7
pubmed: 19907358
J Infect Dis. 2013 Oct 15;208(8):1305-14
pubmed: 23863950
J Clin Virol. 2010 Mar;47(3):263-7
pubmed: 20080440
Nat Rev Microbiol. 2018 Jan;16(1):47-60
pubmed: 29081496
J Clin Virol. 2014 Mar;59(3):208-11
pubmed: 24447853
Clin Microbiol Rev. 2012 Apr;25(2):297-317
pubmed: 22491773
Nat Rev Dis Primers. 2018 Jun 28;4(1):3
pubmed: 29955068
PLoS One. 2019 Jan 11;14(1):e0210353
pubmed: 30633778
Vaccine. 2020 Dec 3;38(51):8078-8081
pubmed: 33168346
Public Health Rep. 2011 May-Jun;126(3):349-53
pubmed: 21553663
BMC Infect Dis. 2012 Oct 23;12:267
pubmed: 23092190
BMC Infect Dis. 2015 Feb 12;15:52
pubmed: 25888024
PLoS One. 2011 Mar 24;6(3):e18176
pubmed: 21455313
PLoS One. 2011 Apr 18;6(4):e18928
pubmed: 21533115
J Clin Microbiol. 2015 Apr;53(4):1172-7
pubmed: 25631799
PLoS One. 2015 Jun 11;10(6):e0128580
pubmed: 26068416
Influenza Other Respir Viruses. 2018 Nov;12(6):780-792
pubmed: 29858537
Lancet Infect Dis. 2004 Jun;4(6):337-48
pubmed: 15172342
J Infect Dis. 2012 Dec 15;206 Suppl 1:S159-65
pubmed: 23169964
PLoS One. 2015 Jun 24;10(6):e0130378
pubmed: 26107509